StockStory Picks Alignment Healthcare as a Long-Term Buy, Flags Akamai and Sinclair as Sells

Industry
โดย StockStory·Read original
Summary · why it matters

StockStory highlights Alignment Healthcare as a Wall Street favorite with strong fundamentals, while warning investors to avoid Akamai Technologies and Sinclair despite consensus price targets implying returns above 20%. Alignment Healthcare, a Medicare Advantage provider, posted 45.4% annual revenue growth over two years and a free cash flow margin that jumped 11 percentage points over five years. Akamai faces underwhelming billings growth of 6.8%, a gross margin of 58.3% that trails competitors, and an expected 25.3 percentage point drop in free cash flow margin. Sinclair has seen sales decline 11.4% annually over five years and carries a 7× net-debt-to-EBITDA ratio that may force dilutive equity offerings.

Impact on stocks 3

Cloud & Digital Infrastructure▼ · 1 stocks
Akamai Technologies Inc
AKAM
▼ NegativeCapitalrelevance

StockStory flags Akamai as a sell due to underwhelming billings growth, low gross margin, and expected free cash flow margin drop.

Aging Population▲ · 1 stocks
Alignment Healthcare LLC
ALHC
▲ PositiveCapitalrelevance

StockStory highlights Alignment Healthcare as a long-term buy with strong revenue growth and improving free cash flow margin.

Communication Services▼ · 1 stocks
Sinclair Broadcast Group Inc
SBGI
▼ NegativeCapitalrelevance

StockStory warns against Sinclair due to declining sales and high leverage that may force dilutive equity offerings.

© 2026 MarketDXNews